NEUE DIAZENIUMDIOLAT-DERIVATE, IHR HERSTELLUNGSVERFAHREN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

NEUE DIAZENIUMDIOLAT-DERIVATE, IHR HERSTELLUNGSVERFAHREN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

Compounds of formula (I): wherein: R1 represents a hydrogen atom or a -COOR group, R2 represents a group G or a linear or branched (C1-C6)alkyl group substituted by a group G, wherein G represents a -(CH2)n-A-(CH2)m-B-(CR4R5)p-(CH2)o-R6 group as defined in the description, R3 represents a hydrogen a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CORDI ALEXIS, HABERKORN LAURE, COURCHAY CHRISTINE, SIMONET SERGE, VERBEUREN TONY
Format: Patent
Sprache:ger
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CORDI ALEXIS
HABERKORN LAURE
COURCHAY CHRISTINE
SIMONET SERGE
VERBEUREN TONY
description Compounds of formula (I): wherein: R1 represents a hydrogen atom or a -COOR group, R2 represents a group G or a linear or branched (C1-C6)alkyl group substituted by a group G, wherein G represents a -(CH2)n-A-(CH2)m-B-(CR4R5)p-(CH2)o-R6 group as defined in the description, R3 represents a hydrogen atom, an alkyl group or an NO2 group. Medicinal products containing the same which are useful in treating hypertension and cardiovascular pathologies.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE520658TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE520658TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE520658TT13</originalsourceid><addsrcrecordid>eNqNjb0KwjAURrs4iPoO192CP1RcQ_PVBNKrJDcdupQicZJaqO-PHXwAp28553zLbGBEkLaqBdtYa3tzSnINbxsl2JE1ngx8EDgX-Roa-EoZD6bImoIFgcUoJ2ANuhvl6zkVxYbSgNoYVF2DA6SdbfA6Wzz715Q2v11l2wpSmjyN7y5NY_9IQ_p083Vx3J-Li8jh9A_zBfaoOOA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEUE DIAZENIUMDIOLAT-DERIVATE, IHR HERSTELLUNGSVERFAHREN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><source>esp@cenet</source><creator>CORDI ALEXIS ; HABERKORN LAURE ; COURCHAY CHRISTINE ; SIMONET SERGE ; VERBEUREN TONY</creator><creatorcontrib>CORDI ALEXIS ; HABERKORN LAURE ; COURCHAY CHRISTINE ; SIMONET SERGE ; VERBEUREN TONY</creatorcontrib><description>Compounds of formula (I): wherein: R1 represents a hydrogen atom or a -COOR group, R2 represents a group G or a linear or branched (C1-C6)alkyl group substituted by a group G, wherein G represents a -(CH2)n-A-(CH2)m-B-(CR4R5)p-(CH2)o-R6 group as defined in the description, R3 represents a hydrogen atom, an alkyl group or an NO2 group. Medicinal products containing the same which are useful in treating hypertension and cardiovascular pathologies.</description><language>ger</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110915&amp;DB=EPODOC&amp;CC=AT&amp;NR=E520658T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110915&amp;DB=EPODOC&amp;CC=AT&amp;NR=E520658T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CORDI ALEXIS</creatorcontrib><creatorcontrib>HABERKORN LAURE</creatorcontrib><creatorcontrib>COURCHAY CHRISTINE</creatorcontrib><creatorcontrib>SIMONET SERGE</creatorcontrib><creatorcontrib>VERBEUREN TONY</creatorcontrib><title>NEUE DIAZENIUMDIOLAT-DERIVATE, IHR HERSTELLUNGSVERFAHREN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><description>Compounds of formula (I): wherein: R1 represents a hydrogen atom or a -COOR group, R2 represents a group G or a linear or branched (C1-C6)alkyl group substituted by a group G, wherein G represents a -(CH2)n-A-(CH2)m-B-(CR4R5)p-(CH2)o-R6 group as defined in the description, R3 represents a hydrogen atom, an alkyl group or an NO2 group. Medicinal products containing the same which are useful in treating hypertension and cardiovascular pathologies.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjb0KwjAURrs4iPoO192CP1RcQ_PVBNKrJDcdupQicZJaqO-PHXwAp28553zLbGBEkLaqBdtYa3tzSnINbxsl2JE1ngx8EDgX-Roa-EoZD6bImoIFgcUoJ2ANuhvl6zkVxYbSgNoYVF2DA6SdbfA6Wzz715Q2v11l2wpSmjyN7y5NY_9IQ_p083Vx3J-Li8jh9A_zBfaoOOA</recordid><startdate>20110915</startdate><enddate>20110915</enddate><creator>CORDI ALEXIS</creator><creator>HABERKORN LAURE</creator><creator>COURCHAY CHRISTINE</creator><creator>SIMONET SERGE</creator><creator>VERBEUREN TONY</creator><scope>EVB</scope></search><sort><creationdate>20110915</creationdate><title>NEUE DIAZENIUMDIOLAT-DERIVATE, IHR HERSTELLUNGSVERFAHREN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><author>CORDI ALEXIS ; HABERKORN LAURE ; COURCHAY CHRISTINE ; SIMONET SERGE ; VERBEUREN TONY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE520658TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>CORDI ALEXIS</creatorcontrib><creatorcontrib>HABERKORN LAURE</creatorcontrib><creatorcontrib>COURCHAY CHRISTINE</creatorcontrib><creatorcontrib>SIMONET SERGE</creatorcontrib><creatorcontrib>VERBEUREN TONY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CORDI ALEXIS</au><au>HABERKORN LAURE</au><au>COURCHAY CHRISTINE</au><au>SIMONET SERGE</au><au>VERBEUREN TONY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEUE DIAZENIUMDIOLAT-DERIVATE, IHR HERSTELLUNGSVERFAHREN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</title><date>2011-09-15</date><risdate>2011</risdate><abstract>Compounds of formula (I): wherein: R1 represents a hydrogen atom or a -COOR group, R2 represents a group G or a linear or branched (C1-C6)alkyl group substituted by a group G, wherein G represents a -(CH2)n-A-(CH2)m-B-(CR4R5)p-(CH2)o-R6 group as defined in the description, R3 represents a hydrogen atom, an alkyl group or an NO2 group. Medicinal products containing the same which are useful in treating hypertension and cardiovascular pathologies.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE520658TT1
source esp@cenet
title NEUE DIAZENIUMDIOLAT-DERIVATE, IHR HERSTELLUNGSVERFAHREN UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T15%3A43%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CORDI%20ALEXIS&rft.date=2011-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE520658TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true